MADRIGAL PHARMACEUTICALS, INC. - COM (MDGL)

Historical Portfolio Holders from Q2 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
22.6M
Holdings value Q3 2024
$4.75B
Value change Q3 2024
-$127M
Grand Portfolio weight change Q3 2024
0%
Number of holders
248
Number of buys Q3 2024
121
Number of sells Q3 2024
-123
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 22.6M $4.75B -$127M $212.22 256
2024 Q2 22.6M $6.34B +$531M $280.16 262
2024 Q1 20.8M $5.54B +$378M $267.04 272
2023 Q4 19.4M $4.5B +$621M $231.38 231
2023 Q3 17M $2.48B +$281M $146.04 207
2023 Q2 14.8M $3.43B +$220M $231.00 213
2023 Q1 13.9M $3.36B +$107M $242.26 226
2022 Q4 13.3M $3.86B +$563M $290.25 192
2022 Q3 11.7M $763M -$25.6M $64.99 136
2022 Q2 12M $858M -$17.3M $71.58 133
2022 Q1 12M $1.18B +$26.3M $98.12 133
2021 Q4 12M $1.01B +$40.9M $84.74 140
2021 Q3 11M $875M -$34.3M $79.79 127
2021 Q2 11.2M $1.09B -$99.1M $97.41 147
2021 Q1 12.2M $1.43B -$10.2M $116.97 135
2020 Q4 12.3M $1.36B +$68.9M $111.17 133
2020 Q3 11.6M $1.38B +$46.5M $118.73 126
2020 Q2 11.3M $1.27B +$4.79M $113.25 124
2020 Q1 11M $738M +$26.6M $66.76 107
2019 Q4 10.5M $954M +$65.9M $91.11 121
2019 Q3 9.64M $831M -$23.3K $86.22 110
2019 Q2 9.61M $1.01B +$10.3M $104.81 121
2019 Q1 9.46M $1.18B +$61.3M $125.26 135
2018 Q4 8.98M $1.01B -$4.92M $112.72 134
2018 Q3 8.62M $1.85B +$62.9M $214.13 157
2018 Q2 8.12M $2.27B +$574M $279.69 147
2018 Q1 6.33M $739M +$152M $116.79 97
2017 Q4 5.13M $471M +$234M $91.79 87
2017 Q3 2.67M $120M +$29.2M $44.98 48
2017 Q2 2.04M $33.1M +$8.67M $16.26 37
2017 Q1 1.53M $23.6M +$3.03M $15.40 25
2016 Q4 1.35M $20M +$6.29M $14.90 23
2016 Q3 1.01M $12.8M +$12.7M $12.68 25
2016 Q2 79.6K $21K +$21K $0.26 1